IRCT20230212057393N3
Not yet recruiting
Phase 3
Evaluation of the effects of melatonin supplementation in patients with type 2 diabetes: a randomized: double-blind clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Diabetic nephropathy.
- Sponsor
- Mazandaran University of Medical Sciences
- Enrollment
- 38
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with type 2 diabetes whose nephropathy was diagnosed through ACR test (\>30 mg/gr) during a three\-month period
Exclusion Criteria
- •Patients with heart failure
- •Pregnant mothers
- •Lactating mothers
- •Sensitivity to melatonin and its analogues and simultaneous use of interfering drugs such as fluvoxamine,...
- •Patients with urinary tract infections and uncontrolled blood pressure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Evaluation of the effect of melatonin supplementation on vascular diseases in patients with diabetic nephropathyIRCT20200527047584N2Kashan University of Medical Sciences60
Recruiting
Phase 3
The effect of melatonin in patients with diabetic nephropathyIRCT20150606022562N5Kashan University of Medical Sciences60
Recruiting
Phase 3
Melatonin in PCOSPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20210224050490N1Tabriz University of Medical Sciences42
Not yet recruiting
Not Applicable
Investigating the effect of melatonin supplementation in obesityIRCT20080904001197N22Tabriz University of Medical Sciences46
Recruiting
Not Applicable
Effects of Melatonin on Non-alcoholic fatty liver diseaseonalcoholic fatty liver disease (NAFLD).nonalcoholic steatohepatitisIRCT2016061516123N8Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences50